深 滬
undefined undefined
--
NaN.000
NaN.00%
華盛通- 最 高--
- 今 開--
- 振 幅 NaN.00%
- 最 低 --
- 昨 收 --
- 成交額 --
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Palvella Therapeutics' Q1 net loss widens on higher costs
Palvella Therapeutics' Q1 net loss widens on higher costs Overview US rare disease biopharma's Q1 net loss widened as R&D and admin costs increased Company raised $230 mln in equity financing, ending Q1 with $261.9 mln in cash Result Drivers R&D SPENDING - Higher research and development expenses dr
05-07 19:58
UPDATE 2-Zealand unveils buyback, Roche payments; shares rise
UPDATE 2-Zealand unveils buyback, Roche payments; shares rise Recasts; adds shares, CFO comment in paragraphs 2-7 By Jesus Calero and Vera Dvorakova May 7 (Reuters) - Danish drug developer Zealand Pharma ZELA.CO on Thursday unveiled share buyback plans and flagged expected milestone payments from Ro
05-07 13:23
FOREX-Yen jumps as Japan threatens more intervention
FOREX-Yen jumps as Japan threatens more intervention Updates to European early afternoon Yen set for biggest weekly gain in over two months Analysts question long-term impact of intervention, citing weak fundamentals Central banks held rates steady this week ECB and BOJ signal possible hikes in June
05-01 12:15
UPDATE 3-Mastercard profit beats estimates on steady transaction volumes
UPDATE 3-Mastercard profit beats estimates on steady transaction volumes Updates throughout, adds CFO comments in paragraph 4 By Utkarsh Shetti April 30 (Reuters) - Mastercard MA.N beat Wall Street estimates for first-quarter profit on Thursday, as resilient consumer spending supported sustained tra
04-30 20:10
ALX Oncology To Present New Data From Phase 1b/2 Clinical Trial Evaluating Investigational CD47-Inhibitor Evorpacept In Combination With Jazz's Zanidatamab In HER2-Positive mBC At ESMO Breast Cancer 2026 Congress
- Company Will Discuss Data and Report First Quarter 2026 Financial Results on May 8 -SOUTH SAN FRANCISCO, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ((", ALX Oncology", , NASDAQ:ALXO), a
04-30 20:06
WRAPUP 1-US growth likely picked up in first quarter, but consumer spending probably cooled
WRAPUP 1-US growth likely picked up in first quarter, but consumer spending probably cooled Gross domestic product forecast to increase at 2.3% rate Post-shutdown rebound in government spending to account for much of anticipated pickup Consumer spending projected to have slowed further as inflation
04-30 12:00
ALX Oncology publishes 2025 annual report
ALX Oncology publishes 2025 annual report ALX Oncology annual report for fiscal 2025 highlighted continued focus on two clinical-stage programs, CD47 blocker evorpacept, EGFR-targeted ADC ALX2004. Evorpacept strategy shifted toward combinations with Fc-active anti-cancer antibodies to drive antibody
04-23 10:55
UK Stocks-Factors to watch on April 17
UK Stocks-Factors to watch on April 17 April 17 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher on Friday, with futures FFIc1 up 0.1%. * SCHRODERS: Schroders SDR.L shareholders approved a 9.9 billion pound sale of the British asset manager to U.S. rival Nuveen. * ANGLO AMERICAN: Co
04-17 13:34
BRIEF-OpenAI To Spend More Than $20 Billion On Cerebras Chips, Receive Equity Stake - The Information
BRIEF-OpenAI To Spend More Than $20 Billion On Cerebras Chips, Receive Equity Stake - The Information April 16 (Reuters) - OPENAI TO SPEND MORE THAN $20 BILLION ON CEREBRAS CHIPS, RECEIVE EQUITY STAKE - THE INFORMATION CEREBRAS TARGETS $35 BILLION VALUATION IN UPCOMING PUBLIC OFFERING - THE INFORMAT
04-17 09:21
UPDATE 5-Wells Fargo interest income misses expectations, shares fall
UPDATE 5-Wells Fargo interest income misses expectations, shares fall Updates with CFO comments in paragraphs 7,8, 18, loan book details in paragraph 12 Earnings per share beat expectations CFO highlights resilient economy, notes potential impact of higher oil prices Loan book hits $1 trillion Emplo
04-14 18:31
